Klaus Lehmann-Horn Selected Research

Klaus Lehmann-Horn Research Topics

11	Multiple Sclerosis 01/2022 - 08/2008
9	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2022 - 12/2010
3	Autoimmune Diseases (Autoimmune Disease) 04/2016 - 12/2010
2	Tertiary Lymphoid Structures 01/2022 - 01/2021
2	Glioma (Gliomas) 01/2020 - 02/2015
2	Encephalitis (Encephalitis, Rasmussen) 01/2020 - 02/2015
1	Herpes Simplex Encephalitis (Herpes Encephalitis) 06/2022
1	Herpes Simplex 06/2022
1	Lymphocytosis 01/2020
1	Atrophy 11/2019
1	Ganglion Cysts (Ganglion) 11/2019
1	Demyelinating Diseases (Demyelinating Disease) 01/2016
1	Lymphopenia (Lymphocytopenia) 01/2016
1	Epilepsy (Aura) 02/2015
1	Seizures (Absence Seizure) 02/2015
1	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 02/2015
1	Central Nervous System Diseases (CNS Diseases) 02/2015
1	Parkinson Disease (Parkinson's Disease) 03/2009
1	Mitochondrial Diseases (Mitochondrial Disease) 03/2009

5	AntibodiesIBA 09/2017 - 08/2008
4	AntigensIBA 06/2022 - 02/2015
3	Myelin-Oligodendrocyte GlycoproteinIBA 01/2021 - 01/2016
2	Leucine (L-Leucine)FDA Link 01/2020 - 02/2015
2	Immunoglobulins (Immunoglobulin)IBA 01/2020 - 02/2015
2	Oligoclonal BandsIBA 01/2020 - 02/2015
2	anti-leucine-rich glioma-inactivated 1 autoantibodyIBA 01/2020 - 02/2015
2	Proteins (Proteins, Gene)FDA Link 04/2016 - 08/2008
2	Integrin alpha4beta1 (VLA-4)IBA 04/2016 - 05/2015
2	Dimethyl FumarateIBA 01/2016 - 06/2015
1	Antiviral Agents (Antivirals)IBA 06/2022
1	siponimodIBA 01/2022
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2021
1	Retinaldehyde (Retinal)IBA 11/2019
1	salicylhydroxamic acid (SHAM)IBA 11/2019
1	ocrelizumabIBA 01/2018
1	EnzymesIBA 12/2016
1	Cytidine DeaminaseIBA 12/2016
1	Peptides (Polypeptides)IBA 04/2016
1	Natalizumab (Tysabri)FDA Link 05/2015
1	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 02/2015
1	Immunoglobulin G (IgG)IBA 02/2015
1	Pertussis ToxinIBA 12/2010
1	CytokinesIBA 12/2010
1	Virulence Factors (Pathogenicity Factors)IBA 12/2010
1	benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA 03/2009
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 03/2009
1	RotenoneIBA 03/2009
1	TunicamycinIBA 03/2009
1	UbiquitinIBA 03/2009
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 03/2009
1	epoxomicinIBA 03/2009
1	Ligases (Synthetase)IBA 03/2009
1	Interferon-betaIBA 08/2008
1	HLA-DRB1*04:01 antigenIBA 08/2008
1	HLA-DRB1 Chains (HLA DRB1)IBA 08/2008

5	Therapeutics 01/2020 - 08/2008
1	Immunotherapy 02/2015